Gestational diabetes: dilemma caused by multiple international diagnostic criteria
- 29 June 2005
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 22 (12) , 1731-1736
- https://doi.org/10.1111/j.1464-5491.2005.01706.x
Abstract
To highlight the variation in the diagnosis of gestational diabetes (GDM) as defined by six well-accepted international expert panels. Two thousand, five hundred and fifty-four pregnant women underwent a 75-g oral glucose tolerance test for routine, antenatal GDM screening. They were classified using the criteria of the American Diabetes Association, Australasian Diabetes in Pregnancy Society, the Canadian Diabetes Association, the European Association for the Study of Diabetes, the New Zealand Society for the study of Diabetes and the World Health Organization (WHO). Between any two criteria, both the GDM prevalence (range; 7.9-24.9%) and the women classified differently [range; 70 (2.7%)-454 (17.8%) women], was significant (Por=4000 g) incidence (OR; 2.09, 2.01, 1.92, respectively). The guidelines of the various professional committees, being based on consensus and expert opinion, show major discrepancies in their ability to identify women with GDM and their capacity to predict adverse pregnancy outcome. Only evidence-based criteria derived from reliable and consistent scientific data will eliminate the confusion caused in clinical practice.Keywords
This publication has 28 references indexed in Scilit:
- Gestational diabetes: a reappraisal of HBA1c as a screening testActa Obstetricia et Gynecologica Scandinavica, 2005
- Gestational diabetes in a high-risk population: using the fasting plasma glucose to simplify the diagnostic algorithmEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2005
- Recent advances in the treatment of gestational diabetesExpert Opinion on Investigational Drugs, 2004
- Gestational Diabetes MellitusDiabetes Care, 2004
- Screening for Gestational DiabetesObstetrics & Gynecology, 2003
- Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task ForceObstetrics & Gynecology, 2003
- Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic WomenDiabetes, 2002
- The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) StudyInternational Journal of Gynecology & Obstetrics, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002